紫杉醇及其衍生物在局部进展期乳腺癌新辅助化疗中的临床疗效分析(4)
[9] Amar S，Roy V，Perez E A.Treatment of metastatic breast cancer：looking towards the future[J].Breast Cancer Res Treat，2009，114(3)：413-422.
[10] Liu S V，Melstrom L，Yao K，et al.Neoadjuvant therapy for breast cancer[J].J Surg Oneol，2010，101(4)：283-291.
[11] Henderson C，Berry D A，Demetri G D，et al.Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients wieh node-positive primary breast cancer[J].J Clin Oncol，2003，21(6)：976-983.
[12] Opshaughnessy J，Miles D，Vakelja S，et al.Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer：phaseⅢ trial results[J].J Clin Oncol，2002，20(12)：2812-2823.
[13] Jones S E，Erban B，Overmoyer G T，et al.Randomized phase Ⅲ study of docetaxel compared with paclitaxel in metastatic breast cancer[J].J Clin Oncol，2005，23(24)：5542-5551.
[14]王芬.三阴乳腺癌对表阿霉素联合多西紫杉醇新辅助化疗疗效评价[J].中外医学研究，2012，10(1)：142-143.
[15] Yildizeli B，Lacin T，Batirel H F，et al.Complications and management of long term central venous access catheters and ports[J].J Vasc Access，2004，5(4)：174-178.
(收稿日期：2015-08-04)(本文编辑：欧丽), http://www.100md.com(邓江波 罗伙英 吴家宝)
[10] Liu S V，Melstrom L，Yao K，et al.Neoadjuvant therapy for breast cancer[J].J Surg Oneol，2010，101(4)：283-291.
[11] Henderson C，Berry D A，Demetri G D，et al.Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients wieh node-positive primary breast cancer[J].J Clin Oncol，2003，21(6)：976-983.
[12] Opshaughnessy J，Miles D，Vakelja S，et al.Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer：phaseⅢ trial results[J].J Clin Oncol，2002，20(12)：2812-2823.
[13] Jones S E，Erban B，Overmoyer G T，et al.Randomized phase Ⅲ study of docetaxel compared with paclitaxel in metastatic breast cancer[J].J Clin Oncol，2005，23(24)：5542-5551.
[14]王芬.三阴乳腺癌对表阿霉素联合多西紫杉醇新辅助化疗疗效评价[J].中外医学研究，2012，10(1)：142-143.
[15] Yildizeli B，Lacin T，Batirel H F，et al.Complications and management of long term central venous access catheters and ports[J].J Vasc Access，2004，5(4)：174-178.
(收稿日期：2015-08-04)(本文编辑：欧丽), http://www.100md.com(邓江波 罗伙英 吴家宝)